DOBUTamine Injection, USP, 250 mg/20 mL (12.5 mg/mL), 20 mL per Single-dose Vial, carton of 10 Fliptop Vials, Rx only, For Intravenous Use Only, Made in Italy, Distributed by Hospira, Inc., Lake Forest, IL 60045 USA. NDC Carton: 0409-2344-02; NDC Vial: 0409-2344-62
Published July 2, 2025 · Recall initiated: May 28, 2025
Summary
FDA records drug Class II recall D-0489-2025, published July 2, 2025 and initiated May 28, 2025. Recalling firm: Pfizer Inc.; Status: Ongoing; Reported quantity: 98,410 vials; Lot: Lot KA5023, exp 02/28/2026. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Discoloration; discolored solution from cracked vials
What to do
Voluntary: Firm initiated · Letter
Get an email if DOBUTAMINE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- DOBUTAMINE
- Manufacturer
- Pfizer Inc.
- Distributor
- Nationwide in the USA
- Lot
- Lot KA5023, exp 02/28/2026
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDANicotinamide adenine dinucleotide (NAD+): 100mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness,July 2, 2025
- FDA0.9% Sodium Chloride Injection, USP, Flexible Plastic Container, Rx Only Fresenius Medical Care North America,July 2, 2025
- FDATirzepatide/Cyanocobalamin Injectable, 30mg/1mg/mL (15mg/0.5mg/0.5mL), pre-filled syringe, Thrive HealthJuly 2, 2025
- FDA0.9% Sodium Chloride Injection USP, 500 mL, packaged in 500 mL excel containers and further packaged 24 perJuly 2, 2025
- FDATirzepatide/Cyanocobalamin Injectable, 15mg/1mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness,July 2, 2025
- FDADOBUTamine Injection, USP, 250 mg per 20 mL, 20 mL Single-dose Fliptop Vial, Rx only, Manufactured for HospiraAugust 27, 2014
Questions about this recall
Was DOBUTamine Injection, USP, 250 mg/20 mL (12.5 mg/mL), 20 mL per Single-dose Vial, carton of 10 Fliptop Vials, Rx only, For Intravenous Use Only, Made in Italy, Distributed by Hospira, Inc., Lake Forest, IL 60045 USA. NDC Carton: 0409-2344-02; NDC Vial: 0409-2344-62 recalled?
Yes. FDA published recall D-0489-2025 on July 2, 2025. Reported hazard: Discoloration; discolored solution from cracked vials
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: DOBUTAMINE.